Public Health Industrial Base Capabilities and Capacities: Essential Medicines

The ASPR Industrial Base Management and Supply Chain has issued a Request for Information (RFI) focused on enhancing the understanding of the domestic production capabilities and capacities related to essential medicines as defined by Executive Orders 13944 and 14293. This RFI is part of efforts to bolster the public health industrial base (PHIB) in the U.S. and aims to solicit data regarding the production of vital drugs and biologics. Industry partners are invited to provide insights on their ability to produce and supply precursors, key starting materials, and finished dosage forms of 28 specified essential medicines, alongside details regarding regulatory compliance, manufacturing capacities, and supply chain challenges. The submission process allows for confidential trade secrets and emphasizes a structured format for responses, highlighting the government’s intent to use this information for planning rather than forming binding contracts. Ultimately, this initiative reflects the U.S. government’s commitment to reinforcing domestic pharmaceutical manufacturing to ensure readiness for public health emergencies.